231 related articles for article (PubMed ID: 10981873)
1. Expression of MHC class II-associated invariant chain (Ii;CD74) in thymic epithelial neoplasms.
Datta MW; Shahsafaei A; Nadler LM; Freeman GJ; Dorfman DM
Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):210-5. PubMed ID: 10981873
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical staining for bcl-2 and mcl-1 in intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) and cervical thymic carcinoma.
Dorfman DM; Shahsafaei A; Miyauchi A
Mod Pathol; 1998 Oct; 11(10):989-94. PubMed ID: 9796728
[TBL] [Abstract][Full Text] [Related]
3. Expression of invariant chain (CD 74) and major histocompatibility complex (MHC) class II antigens in the human fetus.
Badve S; Deshpande C; Hua Z; Lögdberg L
J Histochem Cytochem; 2002 Apr; 50(4):473-82. PubMed ID: 11897800
[TBL] [Abstract][Full Text] [Related]
4. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile.
Kuo TT; Chan JK
Am J Surg Pathol; 1998 Dec; 22(12):1474-81. PubMed ID: 9850173
[TBL] [Abstract][Full Text] [Related]
5. Metaplastic thymoma: report of an unusual thymic epithelial neoplasm arising in the wall of a thymic cyst.
Poorabdollah M; Mehdizadeh E; Mohammadi F; Sabeti S
Int J Surg Pathol; 2009 Feb; 17(1):51-4. PubMed ID: 18397900
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of Mcl-1 and bcl-2 proteins in thymic epithelial tumours.
Chen FF; Yan JJ; Chang KC; Lai WW; Chen RM; Jin YT
Histopathology; 1996 Dec; 29(6):541-7. PubMed ID: 8971561
[TBL] [Abstract][Full Text] [Related]
7. Impaired expression of MHC class II molecules in response to interferon-gamma (IFN-gamma) on human thymoma neoplastic epithelial cells.
Inoue M; Okumura M; Miyoshi S; Shiono H; Fukuhara K; Kadota Y; Shirakura R; Matsuda H
Clin Exp Immunol; 1999 Jul; 117(1):1-7. PubMed ID: 10403908
[TBL] [Abstract][Full Text] [Related]
8. The MIC2 antibody 013. Practical application for the study of thymic epithelial tumors.
Chan JK; Tsang WY; Seneviratne S; Pau MY
Am J Surg Pathol; 1995 Oct; 19(10):1115-23. PubMed ID: 7573670
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and clinical significance of KIT(CD117) expression in thymic epithelial tumors in China.
Song N; Chen G; Zhang P; Liu M; He WX; Jiang GN
Asian Pac J Cancer Prev; 2012; 13(6):2745-8. PubMed ID: 22938452
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of CLIP:MHC class II and conventional endogenous peptide:MHC class II complexes by thymic epithelial cells and peripheral antigen-presenting cells.
Farr A; DeRoos PC; Eastman S; Rudensky AY
Eur J Immunol; 1996 Dec; 26(12):3185-93. PubMed ID: 8977321
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic utility of thymic epithelial markers CD205 (DEC205) and Foxn1 in thymic epithelial neoplasms.
Nonaka D; Henley JD; Chiriboga L; Yee H
Am J Surg Pathol; 2007 Jul; 31(7):1038-44. PubMed ID: 17592270
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma.
Hishima T; Fukayama M; Hayashi Y; Fujii T; Arai K; Shiozawa Y; Funata N; Koike M
Hum Pathol; 1998 Apr; 29(4):330-8. PubMed ID: 9563781
[TBL] [Abstract][Full Text] [Related]
13. Activation of the mTOR/ Akt pathway in thymic epithelial cells derived from thymomas.
Maury JM; Merveilleux du Vignaux C; Drevet G; Zarza V; Chalabreysse L; Maisse C; Gineys B; Dolmazon C; Tronc F; Girard N; Leroux C
PLoS One; 2019; 14(3):e0197655. PubMed ID: 30897085
[TBL] [Abstract][Full Text] [Related]
14. Expression of apoptosis-related markers and HER-2/neu in thymic epithelial tumours.
Pan CC; Chen PC; Wang LS; Lee JY; Chiang H
Histopathology; 2003 Aug; 43(2):165-72. PubMed ID: 12877732
[TBL] [Abstract][Full Text] [Related]
15. Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs).
Tiseo M; Damato A; Longo L; Barbieri F; Bertolini F; Stefani A; Migaldi M; Gnetti L; Camisa R; Bordi P; Buti S; Rossi G
Lung Cancer; 2017 Feb; 104():24-30. PubMed ID: 28212996
[TBL] [Abstract][Full Text] [Related]
16. Staging of thymic epithelial neoplasms: thymoma and thymic carcinoma.
Weissferdt A; Moran CA
Pathol Res Pract; 2015 Jan; 211(1):2-11. PubMed ID: 25441660
[TBL] [Abstract][Full Text] [Related]
17. Tumour eosinophilia combined with an immunohistochemistry panel is useful in the differentiation of type B3 thymoma from thymic carcinoma.
Khoury T; Chandrasekhar R; Wilding G; Tan D; Cheney RT
Int J Exp Pathol; 2011 Apr; 92(2):87-96. PubMed ID: 21044186
[TBL] [Abstract][Full Text] [Related]
18. Proliferative activity and apoptosis in thymic epithelial neoplasms.
Hiroshima K; Iyoda A; Toyozaki T; Supriatna Y; Shibuya K; Shimamura F; Haga Y; Yoshida S; Fujisawa T; Ohwada H
Mod Pathol; 2002 Dec; 15(12):1326-32. PubMed ID: 12481014
[TBL] [Abstract][Full Text] [Related]
19. Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity.
Dorfman DM; Shahsafaei A; Chan JK
Am J Surg Pathol; 1997 Aug; 21(8):936-40. PubMed ID: 9255257
[TBL] [Abstract][Full Text] [Related]
20. Expression of pRb and p16INK4 in human thymic epithelial tumors in relation to the presence of human polyomavirus 7.
Keijzers M; Rensspiess D; Pujari S; Abdul-Hamid MA; Hochstenbag M; Dingemans AM; Kurz AK; Haugg A; Maessen JG; De Baets MH; Zur Hausen A
Diagn Pathol; 2015 Nov; 10():201. PubMed ID: 26537237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
